Irbesartan And Hydrochlorothiazide Tablet
Product Images NDC 71335-1787

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 71335-1787). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1a.jpg (Figure1a)

Figure1a.jpg (Figure1a)
This appears to be a table or graph showing the baseline systolic blood pressure (SBP) in millimeters of mercury (mmHg) for five different studies (labeled Irb.-HCTZ Study V, Irb. Study VI, etc.). It is difficult to interpret without additional context or the complete data set.*
FDA Label Image

Figure1b.jpg (Figure1b)

Figure1b.jpg (Figure1b)
This text appears to be a table or chart showing blood pressure measurements (baseline systolic blood pressure in mmHg) for two different studies, "Irb.-HCTZ Study V" and "Irb.-HCTZ Study VI". The table includes measurements ranging from 100 mmHg to 220 mmHg. There is not enough context to provide a full description of the purpose or results of these studies.*
FDA Label Image

Figure2a.jpg (Figure2a)

Figure2a.jpg (Figure2a)
This appears to be a list of study names that involve the medications Irb and HCTZ in various combinations, as well as a chart showing baseline diastolic blood pressure measurements. No additional information is provided.*
FDA Label Image

Figure2b.jpg (Figure2b)

Figure2b.jpg (Figure2b)
This appears to be a graph showing the results of two studies (Study V and Study VI) with different treatments for high blood pressure (Irb.-HCTZ and Irb.), as well as a baseline measurement. The x-axis appears to show baseline diastolic blood pressure (DBP) measurements in mmHg and the y-axis shows the percentage of patients with DBP under 80 mmHg.*
FDA Label Image

Figure3.jpg (Figure3)

Figure3.jpg (Figure3)
This appears to be a table showing different dosages of Irbesartan, a medication used for treating high blood pressure. The dosages are listed in milligrams per day and range from 300 to 900.*
FDA Label Image

Figure4.jpg (Figure4)

Figure4.jpg (Figure4)
This is a list of numerical values that represent various dosages of Irbesartan, a medication commonly used to treat high blood pressure. No further information or context is given.*
FDA Label Image

Hydrochlorothiazide.jpg (Hydrochlorothiazide)

FDA Label Image

Label (Lbl713351787)

Label (Lbl713351787)
This is a description of a medicine called "Irbesartan and Hydrochlorothiazide Tablets, USP". Each tablet contains 150 mg of Irbesartan and 12.5 mg of Hydrochlorothiazide. The medicine is to be kept away from children and stored at 20° to 25° C (68° to 77° F), with permitted excursions to 15° to 30° C (59° to 86° F). The box contains 30 tablets.*
FDA Label Image

Lbl7133517872

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.